ENG/中
美国
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
亚什兰
53.08
-4.7900
-8.28%
盘后:
53.08
0.0000
0.00%
16:20 EDT
成交量:
69.94万
成交额:
3,745.57万
市值:
25.04亿
市盈率:
-115.76
高:
56.28
开:
55.73
低:
52.98
收:
57.87
数据加载中...
总览
公司
新闻
公告
2024 ASH | 与标准治疗相比,CARVYKTI® 显著提高了复发或难治性多发性骨髓瘤患者MRD阴性率
美通社
·
2024-12-10
康诺亚-B(02162):CM336 I/II期临床研究最新数据在第66届美国血液学会(ASH)年会上以壁报形式公布
智通财经
·
2024-12-09
令人鼓舞的疗效和安全性 基石药业在ASH年会上公布CS5001针对晚期淋巴瘤的最新临床数据
智通财经
·
2024-12-09
和誉-B:和誉医药在ASH年会上展示匹米替尼治疗cGvHD的初步II期积极研究结果
新浪港股
·
2024-12-09
和誉-B(02256):和誉医药在第66届ASH年会上展示匹米替尼治疗cGvHD的初步II期积极研究结果
智通财经
·
2024-12-08
港股异动 | 科济药业-B(02171)涨超5% 赛恺泽®、CT071和CT0590数据即将于2024年ASH年会上展示
智通财经
·
2024-12-05
细胞凋亡疗法的“关键一跃”
锦缎
·
2024-11-22
Ashland Inc.2024财年实现净利润1.99亿美元,同比增加18.45%
市场透视
·
2024-11-16
港股异动 | 和誉-B(02256)逆市涨超7% 将于ASH会议展示慢性移植物抗宿主病新药初步研究结果
智通财经
·
2024-11-11
港股异动 | 和誉-B(02256)午后涨超13% 和誉医药将在ASH年会发布匹米替尼的初步II期研究数据
智通财经
·
2024-11-08
Ashland Inc.盘中异动 大幅跳水7.67%报80.68美元
市场透视
·
2024-11-07
又有利好!最牛飙升近30%
市场资讯
·
2024-11-07
【2024 ASH】 亚盛医药Bcl-2抑制剂APG-2575三项临床研究入选,含1项口头报告!
美通社
·
2024-11-06
【2024 ASH】七连冠!耐立克携多项研究第七次入选,其中1项获口头报告
美通社
·
2024-11-06
亚盛医药将在ASH年会展示新药临床进展
财中社
·
2024-11-06
基石药业将于ASH年会公布CS5001淋巴瘤适应症临床数据
财中社
·
2024-11-06
亚盛医药-B(06855):耐立克®、lisaftoclax、APG-5918及APG-2449的多项临床进展将在2024年美国血液学会年会(ASH)展示,其中两项获口头报告
智通财经
·
2024-11-06
基石药业-B(02616)将在第66届美国血液学会(ASH)年会上公布 CS5001针对淋巴瘤的最新临床数据
智通财经
·
2024-11-06
科济药业赛恺泽®、CT071和CT0590的数据将于2024年ASH年会上以壁报形式展示
美通社
·
2024-11-06
亚什兰公司 预计每股收益1.28美元 - 财报前瞻
Reuters
·
2024-11-05
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ASH/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASH\",,,,,undefined,":{"symbol":"ASH","market":"US","secType":"STK","nameCN":"亚什兰","latestPrice":53.08,"timestamp":1743710400000,"preClose":57.87,"halted":0,"volume":699365,"hourTrading":{"tag":"盘后","latestPrice":53.08,"preClose":53.08,"latestTime":"16:20 EDT","volume":1198,"amount":63588.82,"timestamp":1743711600385},"delay":0,"floatShares":46615360,"shares":47182862,"eps":-0.458541,"marketStatus":"未开盘","change":-4.79,"latestTime":"04-03 16:00:00 EDT","open":55.73,"high":56.28,"low":52.975,"amount":37455686.688808,"amplitude":0.057111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.458541,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1743753600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":57.87,"dividendRate":0.030143,"preHourTrading":{"tag":"盘前","latestPrice":51.51,"preClose":57.87,"latestTime":"08:59 EDT","volume":56,"amount":2922.7198000000003,"timestamp":1743685177104},"postHourTrading":{"tag":"盘后","latestPrice":53.08,"preClose":53.08,"latestTime":"16:20 EDT","volume":1198,"amount":63588.82,"timestamp":1743711600385},"volumeRatio":1.027911,"impliedVol":0.4363,"impliedVolPercentile":0.952},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASH\",,,,,undefined,":{"symbol":"ASH","floatShares":46615360,"roa":"1.94%","roe":"0.18%","lyrEps":3.448979,"volumeRatio":1.027911,"shares":47182862,"dividePrice":1.6,"high":56.28,"amplitude":0.057111,"preClose":57.87,"low":52.975,"week52Low":52.975,"pbRate":"0.97","psRate":"1.22","week52High":102.5,"institutionHeld":0.8513,"latestPrice":53.08,"eps":-0.458541,"divideRate":0.030143,"volume":699365,"delay":0,"ttmEps":-0.458541,"open":55.73,"prevYearClose":71.46,"prevWeekClose":59.01,"prevMonthClose":59.29,"prevQuarterClose":59.29,"fiveDayClose":59.75,"twentyDayClose":59.64,"sixtyDayClose":71.33},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ASH\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490864365","title":"2024 ASH | 与标准治疗相比,CARVYKTI® 显著提高了复发或难治性多发性骨髓瘤患者MRD阴性率","url":"https://stock-news.laohu8.com/highlight/detail?id=2490864365","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490864365?lang=zh_cn&edition=fundamental","pubTime":"2024-12-10 13:16","pubTimestamp":1733807760,"startTime":"0","endTime":"0","summary":"\" 3期研究CARTITUDE-4评估了CARVYKTI与PVd 或 DPd 的标准疗法在既往接受过一至三线治疗且来那度胺耐药的复发或难治性多发性骨髓瘤成人患者中的疗效。研究进行了随机分组,208名患者接受CARVYKTI治疗,211名患者接受标准治疗。此外,经CARVYKTI 治疗的患者迅速达到了较高的总体MRD阴性率,在第56天时,69%的可评估患者已达到MRD阴性。截至目前,我们已在全球五个国家推出了CARVYKTI,治疗患者人数逾4500名。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4576011_ZH76011_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2463526074.USD","LEGN","BK4588","BK4139","ASH","BK4585","BK4505","BK4109"],"gpt_icon":0},{"id":"2490748167","title":"康诺亚-B(02162):CM336 I/II期临床研究最新数据在第66届美国血液学会(ASH)年会上以壁报形式公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2490748167","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490748167?lang=zh_cn&edition=fundamental","pubTime":"2024-12-09 16:32","pubTimestamp":1733733168,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康诺亚-B 发布公告,其靶向BCMAxCD3的双特异性抗体CM336治疗复发或难治性多发性骨髓瘤的I/II期临床研究最新数据在第66届美国血液学会年会上以壁报形式公布。截至2024年10月30日,该研究共入组68例受试者。安全性评估显示,CM336安全性和耐受性良好。剂量成功递增至160 mg,且尚未达到最大耐受剂量。CM336在治疗复发或难治性多发性骨髓瘤受试者中表现出初步有效性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02162","ASH","BK1583","BK1161","LU2463526074.USD","BK4109","BK1574","BK1587"],"gpt_icon":0},{"id":"2490648977","title":"令人鼓舞的疗效和安全性 基石药业在ASH年会上公布CS5001针对晚期淋巴瘤的最新临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2490648977","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490648977?lang=zh_cn&edition=fundamental","pubTime":"2024-12-09 08:54","pubTimestamp":1733705682,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,12月9日,基石药业宣布,公司在第66届美国血液学会年会上公布管线2.0重磅产品CS5001针对淋巴瘤的最新临床数据。CS5001是目前已知首个在实体瘤和淋巴瘤中均观察到临床疗效的ROR1 ADC。CS5001全球多中心试验目前仍在美国、澳大利亚和中国同步进行,目前剂量递增已完成,近期我们将启动涵盖多瘤种、具有注册潜力的1b期剂量扩展研究。安全性数据剂量递增已完成,截至目前在10个剂量水平上均未报告DLT。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221917.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","LU2463526074.USD","BK4109","ASH","02616"],"gpt_icon":0},{"id":"2490769284","title":"和誉-B:和誉医药在ASH年会上展示匹米替尼治疗cGvHD的初步II期积极研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2490769284","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490769284?lang=zh_cn&edition=fundamental","pubTime":"2024-12-09 08:16","pubTimestamp":1733703360,"startTime":"0","endTime":"0","summary":" 和誉-B发布公告,公司的附属公司上海和誉生物医药科技有限公司在第66届美国血液学会年会上以口头报告形式发布了匹米替尼治疗既往一线或多线治疗失败的慢性移植物抗宿主病患者的初步II期研究结果。尽管大多数入组患者尚未完成cGvHD缓解评估所需的6个月治疗周期,但是其中接受匹米替尼20毫克QD 治疗患者亚组的初步数据显示ORR已达64%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-09/doc-incyvhrw9800882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","BK1515","LU2463526074.USD","BK4109","ASH","09939","LU2488822045.USD","BK1574","02256","BK1161"],"gpt_icon":0},{"id":"2489738229","title":"和誉-B(02256):和誉医药在第66届ASH年会上展示匹米替尼治疗cGvHD的初步II期积极研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2489738229","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489738229?lang=zh_cn&edition=fundamental","pubTime":"2024-12-08 19:19","pubTimestamp":1733656757,"startTime":"0","endTime":"0","summary":"尽管大多数入组患者尚未完成cGvHD缓解评估所需的6个月治疗周期,但是其中接受匹米替尼20毫克QD 治疗患者亚组的初步数据显示ORR已达64%。这些数据共同证明了匹米替尼治疗cGvHD相关的BOS的临床疗效。研究结果表明,匹米替尼在接受多种既往治疗的cGvHD患者中,表现出显著的临床疗效和良好的耐受性。基于最新的临床经验,匹米替尼可能为治疗cGvHD提供一种有前景的全新治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1161","BK4109","LU2463526074.USD","BK1574","LU2488822045.USD","159938","09939","ASH","02256"],"gpt_icon":0},{"id":"2489885464","title":"港股异动 | 科济药业-B(02171)涨超5% 赛恺泽®、CT071和CT0590数据即将于2024年ASH年会上展示","url":"https://stock-news.laohu8.com/highlight/detail?id=2489885464","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489885464?lang=zh_cn&edition=fundamental","pubTime":"2024-12-05 14:45","pubTimestamp":1733381117,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,科济药业-B涨超5%,截至发稿,涨5.75%,报6.8港元,成交额3279.07万港元。消息面上,科济药业此前宣布其产品赛恺泽、CT071和CT0590的数据将在第66届美国血液学会年会上以壁报形式展示,会议将于12月7日至10日举行。科济药业靶向BCMA的通用型CAR-T产品CT0590的首个人体一期试验中,共入组5名受试者,中位随访时间16.6个月。其中3例患者获得缓解,包括2例严格完全缓解和1例部分缓解。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1220733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","BK1587","LU2463526074.USD","02171","ASH","BK4109","BK1585"],"gpt_icon":0},{"id":"2485258260","title":"细胞凋亡疗法的“关键一跃”","url":"https://stock-news.laohu8.com/highlight/detail?id=2485258260","media":"锦缎","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485258260?lang=zh_cn&edition=fundamental","pubTime":"2024-11-22 18:46","pubTimestamp":1732272412,"startTime":"0","endTime":"0","summary":"极有可能成为中国首款,全球第二款细胞凋亡疗法。细胞凋亡疗法即将迎来“关键一跃”,一个崭新的时代或许就要开启。维奈克拉是目前唯一一款上市的细胞凋亡疗法药物,一经上市即获得了投资者的热切关注,并且不负众望的成为营收超20亿美元的重磅药物。无可否认,维奈克拉是一款成功的药物,它成功开启了细胞凋零疗法的大门,并且已经取得了商业化的成功。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8eirccCcNZ7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4097","BK4109","TLS","ASH","LU2463526074.USD"],"gpt_icon":0},{"id":"2483169306","title":"Ashland Inc.2024财年实现净利润1.99亿美元,同比增加18.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483169306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483169306?lang=zh_cn&edition=fundamental","pubTime":"2024-11-16 00:00","pubTimestamp":1731686432,"startTime":"0","endTime":"0","summary":"11月16日,Ashland Inc.公布财报,公告显示公司2024财年净利润为1.99亿美元,同比增加18.45%;其中营业收入为21.13亿美元,同比减少3.56%,每股基本收益为--。机构评级:截至2024年11月16日,当前有9家机构对Ashland Inc.目标价做出预测,其中目标均价为98.33美元,其中最低目标价为92.00美元,最高目标价为105.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000251abc515b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000251abc515b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASH"],"gpt_icon":0},{"id":"2482170212","title":"港股异动 | 和誉-B(02256)逆市涨超7% 将于ASH会议展示慢性移植物抗宿主病新药初步研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2482170212","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482170212?lang=zh_cn&edition=fundamental","pubTime":"2024-11-11 09:38","pubTimestamp":1731289081,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,和誉-B逆市涨超7%,截至发稿,涨7.11%,报2.58港元,成交额1161.03万港元。消息面上,和誉-B发布公告,该公司的附属公司上海和誉生物医药科技有限公司宣布,和誉医药将在第66届美国血液学会年会上以口头报告形式发布其自主研发的CSF-1R抑制剂匹米替尼的一项II期研究数据。此研究调查匹米替尼于治疗既往一线或多线治疗失败的慢性移植物抗宿主病 患者的应用情况。此次ACoP大会将于2024年11月10日至13日在美国菲尼克斯举行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","02256","ASH","LU2463526074.USD","BK4109","BK1161"],"gpt_icon":0},{"id":"2481110389","title":"港股异动 | 和誉-B(02256)午后涨超13% 和誉医药将在ASH年会发布匹米替尼的初步II期研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2481110389","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481110389?lang=zh_cn&edition=fundamental","pubTime":"2024-11-08 15:03","pubTimestamp":1731049380,"startTime":"0","endTime":"0","summary":"消息面上,和誉公布,附属和誉医药将在2024年12月7日至10日于美国加利福尼亚州圣地亚哥举行的第66届美国血液学会年会上,展示其自主研发的CSF-1R抑制剂匹米替尼在治疗慢性移植物抗宿主病患者的初步II期研究结果。此次研究专注于治疗既往一线或多线治疗失败的cGvHD患者。公告中提到,cGvHD是异基因造血干细胞移植后常见的并发症,约30%至70%的患者会发生此病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","LU2488822045.USD","ASH","02256","LU2463526074.USD","BK1574","159938","BK4109","BK1515","BK1161"],"gpt_icon":0},{"id":"2481918601","title":"Ashland Inc.盘中异动 大幅跳水7.67%报80.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481918601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481918601?lang=zh_cn&edition=fundamental","pubTime":"2024-11-07 22:34","pubTimestamp":1730990067,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时34分,Ashland Inc.股票出现异动,股价急速下挫7.67%。截至发稿,该股报80.68美元/股,成交量2.2662万股,换手率0.05%,振幅1.16%。Ashland Inc.股票所在的化学制品行业中,整体涨幅为0.31%。Ashland Inc.公司简介:Ashland Inc 是一家全球性的特种材料公司,服务于广泛的工业市场。Ashland的北美地区中仅包括美国和加拿大,欧洲地区中包括欧洲、中东和非洲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722342795bde6e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722342795bde6e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASH","LU2463526074.USD","BK4109"],"gpt_icon":0},{"id":"2481978169","title":"又有利好!最牛飙升近30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481978169","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481978169?lang=zh_cn&edition=fundamental","pubTime":"2024-11-07 17:40","pubTimestamp":1730972400,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!受政策利好影响,餐饮股涨幅居前,内房股强势上扬。 个股方面,科济药业新药获得初步进展,股价大涨41%;世茂集团涨超29%,体现出近期地产政策支持的初步成效。世茂集团大幅飙升近30%,而金辉控股、富力地产、远洋集团和融创中国等多股上涨超10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2024-11-07/doc-incvfuhv2254228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4109","LU2463526074.USD","ASH"],"gpt_icon":0},{"id":"2481625939","title":"【2024 ASH】 亚盛医药Bcl-2抑制剂APG-2575三项临床研究入选,含1项口头报告!","url":"https://stock-news.laohu8.com/highlight/detail?id=2481625939","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481625939?lang=zh_cn&edition=fundamental","pubTime":"2024-11-06 15:48","pubTimestamp":1730879280,"startTime":"0","endTime":"0","summary":"美国马里兰州罗克维尔市和中国苏州2024年11月6日 /美通社/ --致力于在肿瘤等领域开发创新药物的领先的生物医药企业——亚盛医药今日宣布,公司重点品种APG-2575共有3项临床进展获选第66届美国血液学会年会,其中一项获口头报告。值得一提的是,今年公司四个品种有多项临床和临床前进展入选ASH年会展示及报告,并获两项口头报告。未来,亚盛医药将进一步加速推进临床开发,早日为患者带来更多治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4549381_ZH49381_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["06855","LU2463526074.USD","LU2125909759.SGD","BK4129","BK4109","BK1574","APG","ASH","BK1161","LU2125909916.SGD","LU1923622291.USD"],"gpt_icon":0},{"id":"2481662593","title":"【2024 ASH】七连冠!耐立克携多项研究第七次入选,其中1项获口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2481662593","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481662593?lang=zh_cn&edition=fundamental","pubTime":"2024-11-06 14:07","pubTimestamp":1730873220,"startTime":"0","endTime":"0","summary":"美国马里兰州罗克维尔市和中国苏州2024年11月6日 /美通社/ -- 致力于在肿瘤等领域开发创新药物的领先的生物医药企业——亚盛医药今日宣布,公司原创1类新药奥雷巴替尼有多项临床进展获选第66届美国血液学会年会,其中1项获口头报告。这是该品种的临床进展连续第7年入选ASH年会口头报告,充分体现国际血液学界对其疗效和安全性的认可。第66届ASH年会将于当地时间2024年12月7日至10日间在美国圣地亚哥以线下结合线上的形式举行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4549303_ZH49303_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["ASH","BK4109","06855","BK1161","BK1574","LU2463526074.USD"],"gpt_icon":0},{"id":"2481958876","title":"亚盛医药将在ASH年会展示新药临床进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2481958876","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481958876?lang=zh_cn&edition=fundamental","pubTime":"2024-11-06 09:25","pubTimestamp":1730856351,"startTime":"0","endTime":"0","summary":"财中社11月6日电亚盛医药-B(06855)发布自愿公告,宣布公司在2024年美国血液学会年会(ASH)展示的多项临床进展。此次会议将展示公司4个在研新药(耐立克?、lisaftoclax、APG-5918及APG-2449)的临床及临床前研究进展,其中2项研究将进行口头报告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411063230498185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ASH","BK4109","BK1161","BK1515","BK1574","LU2463526074.USD","09939"],"gpt_icon":0},{"id":"2481830695","title":"基石药业将于ASH年会公布CS5001淋巴瘤适应症临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2481830695","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481830695?lang=zh_cn&edition=fundamental","pubTime":"2024-11-06 09:25","pubTimestamp":1730856322,"startTime":"0","endTime":"0","summary":"财中社11月6日电基石药业-B(02616)发布公告,宣布将在第66届美国血液学会(ASH)年会上公布CS5001针对淋巴瘤的最新临床数据。ASH年会定于2024年12月7日至12月10日在美国加利福尼亚州圣地亚哥举行。CS5001是该公司的一款重磅产品,主要用于治疗晚期淋巴瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411063230498362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4109","LU2463526074.USD","ASH"],"gpt_icon":0},{"id":"2481916662","title":"亚盛医药-B(06855):耐立克®、lisaftoclax、APG-5918及APG-2449的多项临床进展将在2024年美国血液学会年会(ASH)展示,其中两项获口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2481916662","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481916662?lang=zh_cn&edition=fundamental","pubTime":"2024-11-06 08:30","pubTimestamp":1730853051,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亚盛医药-B 发布公告,公司共有4个在研新药的多项临床及临床前研究入选第66届美国血液学会年会展示,其中2项获口头报告。这是该品种的临床进展连续第3 年入选ASH年会。耐立克为一种正处于临床研究阶段的化合物,且尚未在美国获得批准。第66届ASH年会将于当地时间2024年12月7 日至2024年12月10日间在美国加州圣地亚哥以线下结合线上的形式举行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207229.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4129","LU2125909759.SGD","09939","BK1574","BK1161","BK1515","06855","LU2125909916.SGD","APG","LU1923622291.USD","LU2463526074.USD","159938","ASH","BK4109"],"gpt_icon":0},{"id":"2481266122","title":"基石药业-B(02616)将在第66届美国血液学会(ASH)年会上公布 CS5001针对淋巴瘤的最新临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2481266122","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481266122?lang=zh_cn&edition=fundamental","pubTime":"2024-11-06 08:03","pubTimestamp":1730851408,"startTime":"0","endTime":"0","summary":"智通财经APP讯,基石药业-B 发布公告,该公司将在第66届美国血液学会年会上公布管线2.0重磅产品CS5001针对淋巴瘤的最新临床数据。根据本公司在 2024年美国临床肿瘤学会年会上公布其首次人体研究的初步数据,CS5001在不同剂量水平、对于多线经治的晚期实体瘤和淋巴瘤均能表现出良好的耐受性和令人鼓舞的抗肿瘤活性。本公司将在此次ASH年会公布CS5001首次人体研究中针对晚期B-细胞淋巴瘤的最新安全性和有效性数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2463526074.USD","BK4109","02616","ASH","BK1574"],"gpt_icon":0},{"id":"2481660310","title":"科济药业赛恺泽®、CT071和CT0590的数据将于2024年ASH年会上以壁报形式展示","url":"https://stock-news.laohu8.com/highlight/detail?id=2481660310","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481660310?lang=zh_cn&edition=fundamental","pubTime":"2024-11-06 07:45","pubTimestamp":1730850300,"startTime":"0","endTime":"0","summary":"上海2024年11月6日 /美通社/ -- 科济药业,一家主要专注于治疗血液恶性肿瘤和实体瘤的创新CAR-T细胞疗法公司宣布,赛恺泽、CT071和CT0590的数据将于第66届美国血液学会年会上以壁报形式展示,大会将于2024年12月7日至10日举办。在这2例sCR患者中,CAR拷贝数峰值大于280,000 copies/g genomic DNA。本研究的初步结果表明,CT0590通用型CAR-T细胞疗法的安全性可控,同时实现了深度和持久的临床缓解。泽沃基奥仑赛注射液于2019年获得美国FDA的再生医学先","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4548564_ZH48564_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2463526074.USD","BK1585","BK4109","BK1574","02171","ASH","BK1161","BK1587"],"gpt_icon":0},{"id":"2481569711","title":"亚什兰公司 预计每股收益1.28美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481569711","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481569711?lang=zh_cn&edition=fundamental","pubTime":"2024-11-05 06:58","pubTimestamp":1730761103,"startTime":"0","endTime":"0","summary":" * 亚什兰公司将于 11 月 6 日公布截至 0001 年 1 月 1 日的财报,预计该公司的季度收入将有所增长。 * LSEG 的分析师平均预计亚什兰公司的每股收益为 1.28 美元。* 华尔街对亚什兰公司 12 个月目标价的中位数为 102.00 美元,高于上一交易日的收盘价 85.32 美元。11月4日 - 该公司在2024年8月6日发布的截至9月30日的业绩指引中,未计利息、税项、折旧及摊销前的利润为5.3亿美元至1.4亿美元。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"亚什兰公司 预计每股收益1.28美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASH"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":41}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASH\",params:#limit:5,,,undefined,":[{"date":"2025-02-28","symbol":"ASH","amount":0.405,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-01","defaultRemindTime":1740753000000,"name":"亚什兰","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-15","payableDate":"2025-03-01","currency":"USD","dateTimestamp":1740718800000,"payDate":"2025-03-15"},{"market":"US","date":"2025-01-28","symbol":"ASH","fiscalQuarterEnding":"2024/12","expectedEps":0.2,"name":null,"time":"盘后","type":"earning","dateTimestamp":1738040400000,"reportTimeType":"post","actualEps":0.28},{"date":"2024-11-29","symbol":"ASH","amount":0.405,"announcedDate":"2024-11-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-01","defaultRemindTime":1732890600000,"name":"亚什兰","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-15","payableDate":"2024-12-01","currency":"USD","dateTimestamp":1732856400000,"payDate":"2024-12-15"},{"market":"US","date":"2024-11-06","symbol":"ASH","fiscalQuarterEnding":"2024/09","expectedEps":1.33,"name":null,"time":"盘后","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":1.26},{"date":"2024-08-30","symbol":"ASH","amount":0.405,"announcedDate":"2024-08-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-01","defaultRemindTime":1725024600000,"name":"亚什兰","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-15","payableDate":"2024-09-01","currency":"USD","dateTimestamp":1724990400000,"payDate":"2024-09-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASH\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-27","recordDate":"2015-05-29","paymentDate":"2015-06-15","value":0.39,"currency":"USD"},{"executeDate":"2015-08-19","recordDate":"2015-08-21","paymentDate":"2015-09-15","value":0.39,"currency":"USD"},{"executeDate":"2015-11-27","recordDate":"2015-12-01","paymentDate":"2015-12-15","value":0.39,"currency":"USD"},{"executeDate":"2016-02-17","recordDate":"2016-02-19","paymentDate":"2016-03-15","value":0.39,"currency":"USD"},{"executeDate":"2016-06-01","recordDate":"2016-06-03","paymentDate":"2016-06-15","value":0.39,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.4545,"hold":0.2727,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4545,"analysts":11,"updateTime":1743048000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASH","date":"2025-04-02","current":-123.919353,"percent":0.025662,"low":-152.607239,"twenty":-10.337345,"median":17.87218,"eighty":27.96129,"high":41.666396,"avg":4.115974,"sd":36.077466,"marketCap":2726225766},"quantilePoints":[{"date":"2020-04-09","current":5.936179,"twenty":11.140188,"median":16.854802,"eighty":45.054187,"marketCap":3472664459},{"date":"2020-04-17","current":5.849669,"twenty":11.023535,"median":16.855926,"eighty":45.060758,"marketCap":3422056580},{"date":"2020-04-24","current":5.830102,"twenty":10.902122,"median":16.855926,"eighty":45.060758,"marketCap":3410609559},{"date":"2020-05-01","current":6.059763,"twenty":10.78415,"median":16.855926,"eighty":45.060758,"marketCap":3544961429},{"date":"2020-05-08","current":-51.569829,"twenty":10.709199,"median":16.855926,"eighty":45.060758,"marketCap":3764597548},{"date":"2020-05-15","current":-48.919702,"twenty":10.615504,"median":16.855926,"eighty":45.060758,"marketCap":3571138223},{"date":"2020-05-22","current":-52.571909,"twenty":9.138439,"median":16.855926,"eighty":45.060758,"marketCap":3837749355},{"date":"2020-05-29","current":-55.619556,"twenty":9.120788,"median":16.855926,"eighty":45.060758,"marketCap":4060227579},{"date":"2020-06-05","current":-59.636156,"twenty":9.07954,"median":16.855926,"eighty":45.060758,"marketCap":4353439368},{"date":"2020-06-12","current":-55.13922,"twenty":9.032533,"median":16.855926,"eighty":45.060758,"marketCap":4025163076},{"date":"2020-06-19","current":-56.936338,"twenty":8.983635,"median":16.855926,"eighty":45.060758,"marketCap":4156352681},{"date":"2020-06-26","current":-55.08953,"twenty":8.930444,"median":16.855926,"eighty":45.060758,"marketCap":4021535714},{"date":"2020-07-02","current":-57.723095,"twenty":8.872607,"median":16.855926,"eighty":45.060758,"marketCap":4213785918},{"date":"2020-07-10","current":-57.093689,"twenty":8.675995,"median":16.855926,"eighty":45.060758,"marketCap":4167839328},{"date":"2020-07-17","current":-63.354616,"twenty":8.557057,"median":16.855926,"eighty":45.060758,"marketCap":4624886983},{"date":"2020-07-24","current":-64.439512,"twenty":8.367293,"median":16.855926,"eighty":45.060758,"marketCap":4704084394},{"date":"2020-07-31","current":-44.748169,"twenty":8.317859,"median":16.855926,"eighty":45.060758,"marketCap":4564313264},{"date":"2020-08-07","current":-47.060277,"twenty":8.104676,"median":16.855926,"eighty":45.060758,"marketCap":4800148210},{"date":"2020-08-14","current":-45.655227,"twenty":7.849302,"median":16.855926,"eighty":45.060758,"marketCap":4656833127},{"date":"2020-08-21","current":-44.599957,"twenty":7.651738,"median":16.855926,"eighty":45.060758,"marketCap":4549195639},{"date":"2020-08-28","current":-44.718527,"twenty":7.25977,"median":16.855926,"eighty":45.060758,"marketCap":4561289739},{"date":"2020-09-04","current":-44.196821,"twenty":6.363575,"median":16.855926,"eighty":45.060758,"marketCap":4508075700},{"date":"2020-09-11","current":-43.260121,"twenty":6.075417,"median":16.855926,"eighty":45.060758,"marketCap":4412532312},{"date":"2020-09-18","current":-42.133709,"twenty":5.834015,"median":16.855926,"eighty":45.060758,"marketCap":4297638363},{"date":"2020-09-25","current":-41.013227,"twenty":5.699102,"median":16.855926,"eighty":45.060758,"marketCap":4183349120},{"date":"2020-10-02","current":-42.044782,"twenty":5.471088,"median":16.855926,"eighty":45.060758,"marketCap":4288567789},{"date":"2020-10-09","current":-44.101965,"twenty":5.216092,"median":16.855926,"eighty":45.060758,"marketCap":4498400420},{"date":"2020-10-16","current":-45.258019,"twenty":4.885092,"median":16.855926,"eighty":45.060758,"marketCap":4616317893},{"date":"2020-10-23","current":-44.754098,"twenty":4.479735,"median":16.855926,"eighty":45.060758,"marketCap":4564917969},{"date":"2020-10-30","current":-41.363007,"twenty":-40.555548,"median":16.855926,"eighty":45.060758,"marketCap":4219026715},{"date":"2020-11-06","current":-44.754098,"twenty":-41.328622,"median":16.855926,"eighty":45.060758,"marketCap":4564917969},{"date":"2020-11-13","current":-9.712181,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4933788013},{"date":"2020-11-20","current":-9.201515,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4674369572},{"date":"2020-11-27","current":-9.108247,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4626989343},{"date":"2020-12-04","current":-8.938913,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4540967808},{"date":"2020-12-11","current":-9.025329,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4584867159},{"date":"2020-12-18","current":-9.373926,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4761954621},{"date":"2020-12-24","current":-9.457494,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4804407095},{"date":"2020-12-31","current":-9.455107,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4803194167},{"date":"2021-01-08","current":-10.356446,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":5261074419},{"date":"2021-01-15","current":-10.145138,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":5153730307},{"date":"2021-01-22","current":-10.225125,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":5194363389},{"date":"2021-01-29","current":-9.549419,"twenty":-41.685517,"median":16.84568,"eighty":45.060758,"marketCap":4851104816},{"date":"2021-02-05","current":-10.650636,"twenty":-41.685517,"median":16.798842,"eighty":45.060758,"marketCap":5154907958},{"date":"2021-02-12","current":-10.819853,"twenty":-41.685517,"median":16.763713,"eighty":45.060758,"marketCap":5236808932},{"date":"2021-02-19","current":-10.931411,"twenty":-41.685517,"median":16.727121,"eighty":45.060758,"marketCap":5290802907},{"date":"2021-02-26","current":-10.544092,"twenty":-41.685517,"median":16.708151,"eighty":45.060758,"marketCap":5103340678},{"date":"2021-03-05","current":-10.893807,"twenty":-41.766144,"median":16.655852,"eighty":45.067329,"marketCap":5272602691},{"date":"2021-03-12","current":-11.366361,"twenty":-41.766144,"median":16.626772,"eighty":45.067329,"marketCap":5501318743},{"date":"2021-03-19","current":-11.074305,"twenty":-41.766144,"median":16.605449,"eighty":45.067329,"marketCap":5359963729},{"date":"2021-03-26","current":-11.298674,"twenty":-41.685517,"median":16.565507,"eighty":45.060758,"marketCap":5468558354},{"date":"2021-04-01","current":-11.32625,"twenty":-41.685517,"median":16.544159,"eighty":45.032615,"marketCap":5481905179},{"date":"2021-04-09","current":-11.130711,"twenty":-41.766144,"median":16.513421,"eighty":45.025182,"marketCap":5387264054},{"date":"2021-04-16","current":-11.373882,"twenty":-41.766144,"median":16.49824,"eighty":44.88663,"marketCap":5504958787},{"date":"2021-04-23","current":-11.615799,"twenty":-41.766144,"median":16.458163,"eighty":44.798223,"marketCap":5622046845},{"date":"2021-04-30","current":37.652621,"twenty":-41.766144,"median":16.458163,"eighty":44.763306,"marketCap":5233714269},{"date":"2021-05-07","current":38.556703,"twenty":-41.766144,"median":16.48927,"eighty":44.763306,"marketCap":5359381692},{"date":"2021-05-14","current":38.897371,"twenty":-41.766144,"median":16.508117,"eighty":44.763306,"marketCap":5406734634},{"date":"2021-05-21","current":38.897371,"twenty":-41.766144,"median":16.532217,"eighty":44.763306,"marketCap":5406734634},{"date":"2021-05-28","current":41.421813,"twenty":-41.766144,"median":16.539302,"eighty":44.763306,"marketCap":5757632076},{"date":"2021-06-04","current":41.177231,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5723635092},{"date":"2021-06-11","current":40.923913,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5688423930},{"date":"2021-06-18","current":38.067538,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5291387724},{"date":"2021-06-25","current":38.72267,"twenty":-41.766144,"median":16.559996,"eighty":44.763306,"marketCap":5382451074},{"date":"2021-07-02","current":38.32959,"twenty":-41.766144,"median":16.589527,"eighty":44.763306,"marketCap":5327813064},{"date":"2021-07-09","current":38.399471,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5337526488},{"date":"2021-07-16","current":37.713766,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5242213515},{"date":"2021-07-23","current":38.233504,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5314457106},{"date":"2021-07-30","current":28.544675,"twenty":-41.766144,"median":16.63409,"eighty":44.763306,"marketCap":5166586254},{"date":"2021-08-06","current":28.329928,"twenty":-41.766144,"median":16.642592,"eighty":44.763306,"marketCap":5127716909},{"date":"2021-08-13","current":29.118455,"twenty":-41.766144,"median":16.707431,"eighty":44.763306,"marketCap":5270440286},{"date":"2021-08-20","current":28.051427,"twenty":-41.766144,"median":16.798988,"eighty":44.763306,"marketCap":5077308227},{"date":"2021-08-27","current":29.259383,"twenty":-41.766144,"median":16.876011,"eighty":44.763306,"marketCap":5295948294},{"date":"2021-09-03","current":31.51759,"twenty":-41.685517,"median":16.928602,"eighty":44.762757,"marketCap":5704683753},{"date":"2021-09-10","current":31.051184,"twenty":-41.685517,"median":16.94157,"eighty":44.762757,"marketCap":5620264394},{"date":"2021-09-17","current":30.272724,"twenty":-41.685517,"median":16.987677,"eighty":44.762757,"marketCap":5479363017},{"date":"2021-09-24","current":31.121649,"twenty":-41.685517,"median":16.987677,"eighty":44.762757,"marketCap":5633018398},{"date":"2021-10-01","current":30.59149,"twenty":-41.685517,"median":19.684212,"eighty":44.762757,"marketCap":5537059701},{"date":"2021-10-08","current":31.071317,"twenty":-41.685517,"median":19.787677,"eighty":44.762757,"marketCap":5623908395},{"date":"2021-10-15","current":32.124923,"twenty":-41.685517,"median":19.83941,"eighty":44.762757,"marketCap":5814611120},{"date":"2021-10-22","current":32.826209,"twenty":-41.685517,"median":19.917009,"eighty":44.762757,"marketCap":5941543826},{"date":"2021-10-29","current":32.21552,"twenty":-41.604889,"median":19.999764,"eighty":44.762207,"marketCap":5831009125},{"date":"2021-11-05","current":32.916806,"twenty":-41.604889,"median":20.15896,"eighty":44.762207,"marketCap":5957941831},{"date":"2021-11-12","current":29.342491,"twenty":-41.604889,"median":20.28364,"eighty":44.762207,"marketCap":6455347984},{"date":"2021-11-19","current":30.162391,"twenty":-41.604889,"median":20.500749,"eighty":44.762207,"marketCap":6635726039},{"date":"2021-11-26","current":26.923508,"twenty":-41.604889,"median":20.528215,"eighty":44.762207,"marketCap":5923171764},{"date":"2021-12-03","current":26.411959,"twenty":-41.604889,"median":20.552965,"eighty":44.762207,"marketCap":5810630932},{"date":"2021-12-10","current":27.165993,"twenty":-41.604889,"median":20.676932,"eighty":44.762207,"marketCap":5976518382},{"date":"2021-12-17","current":26.837476,"twenty":-41.604889,"median":20.708356,"eighty":44.762207,"marketCap":5904244736},{"date":"2021-12-23","current":26.982334,"twenty":-41.604889,"median":20.728755,"eighty":44.762207,"marketCap":5936113430},{"date":"2021-12-31","current":27.848893,"twenty":-41.604889,"median":20.764302,"eighty":44.762207,"marketCap":6126756513},{"date":"2022-01-07","current":26.876277,"twenty":-41.524262,"median":20.796751,"eighty":44.761658,"marketCap":5912780993},{"date":"2022-01-14","current":27.341891,"twenty":-41.524262,"median":20.868148,"eighty":44.761658,"marketCap":6015216083},{"date":"2022-01-21","current":25.013821,"twenty":-41.524262,"median":20.917445,"eighty":44.761658,"marketCap":5503040636},{"date":"2022-01-28","current":24.677544,"twenty":-41.524262,"median":20.980342,"eighty":44.761658,"marketCap":5429059738},{"date":"2022-02-04","current":25.572734,"twenty":-41.443634,"median":21.023702,"eighty":44.761108,"marketCap":5421419569},{"date":"2022-02-11","current":25.553938,"twenty":-41.443634,"median":21.065338,"eighty":44.761108,"marketCap":5417434905},{"date":"2022-02-18","current":25.494866,"twenty":-41.443634,"median":21.115412,"eighty":44.761108,"marketCap":5404911676},{"date":"2022-02-25","current":25.29617,"twenty":-41.443634,"median":21.157984,"eighty":44.761108,"marketCap":5362788089},{"date":"2022-03-04","current":23.572347,"twenty":-41.443634,"median":21.240692,"eighty":44.761108,"marketCap":4997337504},{"date":"2022-03-11","current":23.66901,"twenty":-41.443634,"median":21.332705,"eighty":44.761108,"marketCap":5017830061},{"date":"2022-03-18","current":25.352557,"twenty":-41.443634,"median":21.402701,"eighty":44.761108,"marketCap":5374742080},{"date":"2022-03-25","current":26.448071,"twenty":-41.443634,"median":21.507199,"eighty":44.761108,"marketCap":5606991049},{"date":"2022-04-01","current":26.544734,"twenty":-41.443634,"median":21.611248,"eighty":44.761108,"marketCap":5627483605},{"date":"2022-04-08","current":26.703154,"twenty":-41.443634,"median":21.681627,"eighty":44.761108,"marketCap":5661068628},{"date":"2022-04-14","current":28.520955,"twenty":-41.443634,"median":21.86021,"eighty":44.761108,"marketCap":6046442530},{"date":"2022-04-22","current":27.734226,"twenty":-41.443634,"median":22.114023,"eighty":44.761108,"marketCap":5879655893},{"date":"2022-04-29","current":5.98168,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5724467780},{"date":"2022-05-06","current":5.79477,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5545595204},{"date":"2022-05-13","current":5.627805,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5385809640},{"date":"2022-05-20","current":5.695617,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5450705483},{"date":"2022-05-27","current":6.155649,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5890955748},{"date":"2022-06-03","current":6.053281,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5792989652},{"date":"2022-06-10","current":5.809521,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5559711268},{"date":"2022-06-17","current":5.398352,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5166223136},{"date":"2022-06-24","current":5.835537,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5584608729},{"date":"2022-07-01","current":5.86325,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5611129938},{"date":"2022-07-08","current":5.737128,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5490431377},{"date":"2022-07-15","current":5.58499,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5344835356},{"date":"2022-07-22","current":5.922634,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5667961098},{"date":"2022-07-29","current":5.951187,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5439385116},{"date":"2022-08-05","current":6.14725,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5618586516},{"date":"2022-08-12","current":6.304219,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5762055916},{"date":"2022-08-19","current":6.275787,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5736069006},{"date":"2022-08-26","current":6.098679,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5574192212},{"date":"2022-09-02","current":5.884253,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5378207598},{"date":"2022-09-09","current":6.054846,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5534129059},{"date":"2022-09-16","current":5.848121,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5345182567},{"date":"2022-09-23","current":5.752755,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5258018139},{"date":"2022-09-30","current":5.625403,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5141618438},{"date":"2022-10-07","current":5.617703,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5134580316},{"date":"2022-10-14","current":5.641396,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5156236075},{"date":"2022-10-21","current":5.922755,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5413398206},{"date":"2022-10-28","current":6.27401,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5734444824},{"date":"2022-11-04","current":5.909724,"twenty":-41.524262,"median":21.695313,"eighty":44.761658,"marketCap":5401487538},{"date":"2022-11-11","current":6.292902,"twenty":-41.524262,"median":21.556282,"eighty":44.761658,"marketCap":5833519919},{"date":"2022-11-18","current":6.534105,"twenty":-41.524262,"median":9.134384,"eighty":44.761658,"marketCap":6057115624},{"date":"2022-11-25","current":6.524573,"twenty":-41.524262,"median":9.120072,"eighty":44.761658,"marketCap":6048278877},{"date":"2022-12-02","current":6.634386,"twenty":-41.524262,"median":9.077138,"eighty":44.761658,"marketCap":6150076230},{"date":"2022-12-09","current":6.425327,"twenty":-41.524262,"median":9.031818,"eighty":44.761658,"marketCap":5956278049},{"date":"2022-12-16","current":6.216944,"twenty":-41.524262,"median":8.981727,"eighty":44.761658,"marketCap":5763107329},{"date":"2022-12-23","current":6.332842,"twenty":-41.524262,"median":8.929251,"eighty":44.761658,"marketCap":5870544977},{"date":"2022-12-30","current":6.29421,"twenty":-41.524262,"median":8.870812,"eighty":44.761658,"marketCap":5834732428},{"date":"2023-01-06","current":6.238017,"twenty":-41.524262,"median":8.723665,"eighty":44.669031,"marketCap":5782641447},{"date":"2023-01-13","current":6.570492,"twenty":-41.524262,"median":8.558011,"eighty":44.528495,"marketCap":6090846415},{"date":"2023-01-20","current":6.436448,"twenty":-41.524262,"median":8.531792,"eighty":44.433823,"marketCap":5966587722},{"date":"2023-01-27","current":6.301234,"twenty":-41.524262,"median":8.3296,"eighty":44.14834,"marketCap":5841243800},{"date":"2023-02-03","current":6.219087,"twenty":-40.702575,"median":8.3296,"eighty":44.14834,"marketCap":5715340826},{"date":"2023-02-10","current":6.142315,"twenty":-11.558641,"median":8.3296,"eighty":44.14834,"marketCap":5644787763},{"date":"2023-02-17","current":6.10452,"twenty":-11.342294,"median":8.3296,"eighty":44.14834,"marketCap":5610053948},{"date":"2023-02-24","current":6.038378,"twenty":-11.297421,"median":8.3296,"eighty":44.14834,"marketCap":5549269770},{"date":"2023-03-03","current":6.122827,"twenty":-11.1811,"median":8.3296,"eighty":44.14834,"marketCap":5626878140},{"date":"2023-03-10","current":5.75019,"twenty":-11.13773,"median":8.3296,"eighty":44.14834,"marketCap":5284424426},{"date":"2023-03-17","current":5.610229,"twenty":-11.066032,"median":8.3296,"eighty":44.14834,"marketCap":5155800765},{"date":"2023-03-24","current":5.809835,"twenty":-10.976285,"median":8.3296,"eighty":44.14834,"marketCap":5339238729},{"date":"2023-03-31","current":6.065544,"twenty":-10.897567,"median":8.324965,"eighty":44.139273,"marketCap":5574234700},{"date":"2023-04-06","current":5.988772,"twenty":-10.820856,"median":8.324965,"eighty":44.139273,"marketCap":5503681637},{"date":"2023-04-14","current":6.134638,"twenty":-10.775982,"median":8.3296,"eighty":44.14834,"marketCap":5637732457},{"date":"2023-04-21","current":6.151764,"twenty":-10.730374,"median":8.3296,"eighty":44.14834,"marketCap":5653471217},{"date":"2023-04-27","current":5.856489,"twenty":-10.606264,"median":8.340928,"eighty":44.166474,"marketCap":5382113282},{"date":"2023-05-05","current":20.861975,"twenty":-10.43882,"median":8.452838,"eighty":44.175541,"marketCap":4693944269},{"date":"2023-05-12","current":20.287633,"twenty":-10.336151,"median":8.558011,"eighty":44.182524,"marketCap":4564717446},{"date":"2023-05-19","current":21.14158,"twenty":-10.102877,"median":8.693871,"eighty":44.189507,"marketCap":4756855455},{"date":"2023-05-26","current":20.227136,"twenty":-9.78508,"median":8.870812,"eighty":44.196491,"marketCap":4551105489},{"date":"2023-06-02","current":19.892072,"twenty":-9.536436,"median":8.929251,"eighty":44.196491,"marketCap":4475716188},{"date":"2023-06-09","current":20.206194,"twenty":-9.454384,"median":8.98113,"eighty":44.203474,"marketCap":4546393658},{"date":"2023-06-16","current":20.073565,"twenty":-9.376314,"median":9.018699,"eighty":44.210457,"marketCap":4516552059},{"date":"2023-06-23","current":19.475569,"twenty":-9.301666,"median":9.056863,"eighty":44.224123,"marketCap":4382003099},{"date":"2023-06-29","current":19.508145,"twenty":-9.246426,"median":9.092642,"eighty":44.237789,"marketCap":4389332615},{"date":"2023-07-05","current":20.315555,"twenty":-9.193781,"median":9.114705,"eighty":44.251456,"marketCap":4570999888},{"date":"2023-07-14","current":20.455165,"twenty":-9.060547,"median":9.163604,"eighty":44.278788,"marketCap":4602412096},{"date":"2023-07-20","current":21.216038,"twenty":-8.93818,"median":19.183552,"eighty":44.278788,"marketCap":4773608633},{"date":"2023-07-28","current":19.591649,"twenty":4.319692,"median":19.750135,"eighty":44.283744,"marketCap":4682404042},{"date":"2023-08-04","current":19.289348,"twenty":4.38581,"median":19.591649,"eighty":44.129229,"marketCap":4610154209},{"date":"2023-08-11","current":19.13927,"twenty":4.38581,"median":19.482306,"eighty":43.956729,"marketCap":4574285498},{"date":"2023-08-18","current":18.466062,"twenty":4.38581,"median":19.154278,"eighty":43.542383,"marketCap":4413388708},{"date":"2023-08-25","current":18.088722,"twenty":4.38581,"median":18.641868,"eighty":43.319191,"marketCap":4323204519},{"date":"2023-08-31","current":18.781226,"twenty":4.38581,"median":18.466062,"eighty":42.973946,"marketCap":4488713001},{"date":"2023-09-08","current":17.87218,"twenty":4.380867,"median":18.294543,"eighty":42.623722,"marketCap":4271451093},{"date":"2023-09-13","current":17.293307,"twenty":4.378395,"median":18.166977,"eighty":42.388429,"marketCap":4133100350},{"date":"2023-09-22","current":18.005107,"twenty":4.319692,"median":17.86146,"eighty":42.077012,"marketCap":4303220523},{"date":"2023-09-29","current":17.479833,"twenty":4.263461,"median":17.50556,"eighty":41.816324,"marketCap":4177680034},{"date":"2023-10-06","current":17.087485,"twenty":4.263461,"median":17.293307,"eighty":41.73771,"marketCap":4083908975},{"date":"2023-10-13","current":16.418565,"twenty":4.263461,"median":16.945983,"eighty":41.577207,"marketCap":3924037005},{"date":"2023-10-20","current":16.294214,"twenty":4.207231,"median":16.495748,"eighty":41.332109,"marketCap":3894317216},{"date":"2023-10-27","current":16.257767,"twenty":-1.056217,"median":16.28671,"eighty":41.192954,"marketCap":3885606243},{"date":"2023-11-03","current":16.332806,"twenty":-6.207204,"median":16.153784,"eighty":40.948113,"marketCap":3903540598},{"date":"2023-11-10","current":15.616718,"twenty":-6.207204,"median":15.881499,"eighty":40.817223,"marketCap":3732395605},{"date":"2023-11-17","current":16.390693,"twenty":-6.207204,"median":15.574911,"eighty":40.340898,"marketCap":3917375673},{"date":"2023-11-24","current":22.827913,"twenty":-6.207204,"median":15.574911,"eighty":39.96161,"marketCap":4063368468},{"date":"2023-12-01","current":23.015098,"twenty":-8.782697,"median":15.533103,"eighty":39.312288,"marketCap":4096687371},{"date":"2023-12-07","current":23.654406,"twenty":-6.207204,"median":15.574911,"eighty":38.926597,"marketCap":4210484243},{"date":"2023-12-15","current":24.893249,"twenty":-8.782697,"median":15.533103,"eighty":38.72267,"marketCap":4430998377},{"date":"2023-12-22","current":24.325418,"twenty":-8.782697,"median":15.533103,"eighty":38.648421,"marketCap":4329924480},{"date":"2023-12-29","current":24.225549,"twenty":-8.789917,"median":12.47951,"eighty":38.641433,"marketCap":4312147664},{"date":"2024-01-05","current":22.661874,"twenty":-8.797137,"median":9.425916,"eighty":38.597758,"marketCap":4033813516},{"date":"2024-01-12","current":23.423737,"twenty":-8.797137,"median":9.425916,"eighty":38.470225,"marketCap":4169425227},{"date":"2024-01-19","current":22.447867,"twenty":-8.804357,"median":9.30281,"eighty":38.332211,"marketCap":3995720339},{"date":"2024-01-26","current":22.718942,"twenty":-8.797137,"median":9.425916,"eighty":38.217781,"marketCap":4043971696},{"date":"2024-02-02","current":28.85349,"twenty":-8.797137,"median":9.425916,"eighty":38.049194,"marketCap":4731972377},{"date":"2024-02-09","current":27.918791,"twenty":-8.797137,"median":9.425916,"eighty":37.903318,"marketCap":4578681720},{"date":"2024-02-16","current":28.325049,"twenty":-8.797137,"median":9.425916,"eighty":37.631656,"marketCap":4645308051},{"date":"2024-02-23","current":28.413632,"twenty":-8.797137,"median":9.425916,"eighty":37.11978,"marketCap":4659835597},{"date":"2024-03-01","current":28.603015,"twenty":-8.789917,"median":12.47951,"eighty":32.879225,"marketCap":4690894489},{"date":"2024-03-08","current":29.339167,"twenty":-8.789917,"median":12.47951,"eighty":32.536971,"marketCap":4811623405},{"date":"2024-03-15","current":29.363604,"twenty":-8.789917,"median":12.47951,"eighty":32.258469,"marketCap":4815631004},{"date":"2024-03-22","current":29.357495,"twenty":-8.789917,"median":12.47951,"eighty":31.941046,"marketCap":4814629104},{"date":"2024-03-28","current":29.81568,"twenty":-8.789917,"median":12.47951,"eighty":31.40619,"marketCap":4889771583},{"date":"2024-04-05","current":29.122292,"twenty":-8.797137,"median":9.425916,"eighty":31.117622,"marketCap":4776055965},{"date":"2024-04-12","current":29.372767,"twenty":-8.797137,"median":9.425916,"eighty":31.051184,"marketCap":4817133853},{"date":"2024-04-19","current":29.168111,"twenty":-8.797137,"median":9.425916,"eighty":30.606254,"marketCap":4783570213},{"date":"2024-04-26","current":29.079528,"twenty":-8.789917,"median":12.47951,"eighty":30.256618,"marketCap":4769042667},{"date":"2024-05-03","current":24.879315,"twenty":-8.789917,"median":12.47951,"eighty":29.945905,"marketCap":4801707860},{"date":"2024-05-10","current":25.416952,"twenty":-8.789917,"median":12.47951,"eighty":29.757033,"marketCap":4905471669},{"date":"2024-05-17","current":25.614345,"twenty":-8.789917,"median":12.47951,"eighty":29.613467,"marketCap":4943568527},{"date":"2024-05-24","current":25.463703,"twenty":-8.789917,"median":12.47951,"eighty":29.5169,"marketCap":4914494609},{"date":"2024-05-31","current":25.87667,"twenty":-8.789917,"median":12.47951,"eighty":29.365437,"marketCap":4994197245},{"date":"2024-06-07","current":26.035104,"twenty":-8.789917,"median":12.47951,"eighty":29.342276,"marketCap":5024774986},{"date":"2024-06-14","current":25.292282,"twenty":-8.797137,"median":9.425916,"eighty":29.274986,"marketCap":4881410496},{"date":"2024-06-21","current":25.066319,"twenty":-8.804357,"median":9.30281,"eighty":29.230424,"marketCap":4837799620},{"date":"2024-06-28","current":24.487127,"twenty":-8.826676,"median":9.172548,"eighty":29.168722,"marketCap":4726015420},{"date":"2024-07-05","current":24.193634,"twenty":-8.826676,"median":9.172548,"eighty":29.132067,"marketCap":4669371408},{"date":"2024-07-12","current":24.601407,"twenty":-8.826676,"median":9.172548,"eighty":29.097856,"marketCap":4748071495},{"date":"2024-07-15","current":24.596212,"twenty":-8.826676,"median":9.172548,"eighty":29.090525,"marketCap":4747068946},{"date":"2024-08-02","current":24.957234,"twenty":-8.929025,"median":9.114705,"eighty":28.735731,"marketCap":4816746093},{"date":"2024-08-09","current":27.237695,"twenty":-8.929025,"median":9.114705,"eighty":28.677936,"marketCap":4058416549},{"date":"2024-08-16","current":27.91282,"twenty":-8.929025,"median":9.114705,"eighty":28.593851,"marketCap":4159010197},{"date":"2024-08-23","current":28.407693,"twenty":-8.929025,"median":9.114705,"eighty":28.535286,"marketCap":4232746318},{"date":"2024-08-30","current":29.413827,"twenty":-8.929025,"median":9.114705,"eighty":28.535286,"marketCap":4382660153},{"date":"2024-09-06","current":28.273324,"twenty":-8.929025,"median":9.114705,"eighty":28.515633,"marketCap":4212725252},{"date":"2024-09-13","current":27.91282,"twenty":-8.929025,"median":9.114705,"eighty":28.437936,"marketCap":4159010197},{"date":"2024-09-20","current":28.840298,"twenty":-8.929025,"median":9.114705,"eighty":28.414125,"marketCap":4297204384},{"date":"2024-09-27","current":28.584668,"twenty":-8.929025,"median":9.114705,"eighty":28.410315,"marketCap":4259115526},{"date":"2024-10-04","current":27.693241,"twenty":-8.929025,"median":9.114705,"eighty":28.328952,"marketCap":4126292846},{"date":"2024-10-11","current":27.781728,"twenty":-8.929025,"median":9.114705,"eighty":28.174035,"marketCap":4139477450},{"date":"2024-10-18","current":28.768197,"twenty":-8.929025,"median":9.114705,"eighty":28.155826,"marketCap":4286461373},{"date":"2024-10-25","current":27.847274,"twenty":-8.929025,"median":9.114705,"eighty":28.143107,"marketCap":4149243823},{"date":"2024-10-31","current":28.55845,"twenty":-8.929025,"median":9.114705,"eighty":28.102675,"marketCap":4255208977},{"date":"2024-11-08","current":23.317939,"twenty":-8.93818,"median":9.109339,"eighty":27.987673,"marketCap":3940731747},{"date":"2024-11-15","current":22.552233,"twenty":-8.93818,"median":9.109339,"eighty":27.96198,"marketCap":3811327297},{"date":"2024-11-22","current":21.642415,"twenty":-8.93818,"median":9.127228,"eighty":27.96083,"marketCap":3657568070},{"date":"2024-11-29","current":21.759491,"twenty":-8.93818,"median":9.172548,"eighty":27.96083,"marketCap":3677353987},{"date":"2024-12-06","current":21.310698,"twenty":-8.93818,"median":16.14628,"eighty":27.96083,"marketCap":3601507972},{"date":"2024-12-13","current":20.66399,"twenty":-8.93818,"median":16.326374,"eighty":27.96083,"marketCap":3492214336},{"date":"2024-12-20","current":20.056308,"twenty":-8.93818,"median":16.418565,"eighty":27.96083,"marketCap":3389516005},{"date":"2024-12-27","current":20.109271,"twenty":-8.93818,"median":16.564355,"eighty":27.96083,"marketCap":3398466777},{"date":"2025-01-03","current":19.440263,"twenty":-8.93818,"median":16.920255,"eighty":27.96083,"marketCap":3285404395},{"date":"2025-01-10","current":19.6399,"twenty":-8.938327,"median":17.089629,"eighty":27.96106,"marketCap":3319143109},{"date":"2025-01-17","current":19.75157,"twenty":-8.938327,"median":17.49484,"eighty":27.96106,"marketCap":3338015281},{"date":"2025-01-24","current":20.086579,"twenty":-8.938327,"median":17.759622,"eighty":27.96106,"marketCap":3394631794},{"date":"2025-01-31","current":-136.701619,"twenty":-9.032373,"median":17.86146,"eighty":27.96106,"marketCap":3007435623},{"date":"2025-02-07","current":-139.725612,"twenty":-9.144874,"median":17.86146,"eighty":27.96106,"marketCap":3073963459},{"date":"2025-02-14","current":-139.361017,"twenty":-9.245709,"median":17.86146,"eighty":27.96106,"marketCap":3065942372},{"date":"2025-02-21","current":-140.326121,"twenty":-9.301666,"median":17.86146,"eighty":27.96106,"marketCap":3087174660},{"date":"2025-02-28","current":-131.897546,"twenty":-9.377985,"median":17.86146,"eighty":27.96106,"marketCap":2901746013},{"date":"2025-03-07","current":-127.90845,"twenty":-9.455107,"median":17.87218,"eighty":27.96129,"marketCap":2813985889},{"date":"2025-03-14","current":-119.994597,"twenty":-9.579026,"median":17.87218,"eighty":27.96129,"marketCap":2639881128},{"date":"2025-03-21","current":-119.823023,"twenty":-9.954842,"median":17.87218,"eighty":27.96129,"marketCap":2636106499},{"date":"2025-03-28","current":-128.144364,"twenty":-10.210799,"median":17.87218,"eighty":27.96129,"marketCap":2819176004},{"date":"2025-04-02","current":-123.919353,"twenty":-10.337345,"median":17.87218,"eighty":27.96129,"marketCap":2726225766}],"updateTime":1743751978406}}}